|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM121159760 |
| 003 |
DE-627 |
| 005 |
20231222192446.0 |
| 007 |
tu |
| 008 |
231222s1994 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed24n0404.xml
|
| 035 |
|
|
|a (DE-627)NLM121159760
|
| 035 |
|
|
|a (NLM)12287737
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 245 |
1 |
0 |
|a Facts about injectable contraception
|
| 264 |
|
1 |
|c 1994
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 01.12.1994
|
| 500 |
|
|
|a Date Revised 21.11.2013
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Americas
|
| 650 |
|
4 |
|a Contraception
|
| 650 |
|
4 |
|a Contraceptive Agents, Female--side effects
|
| 650 |
|
4 |
|a Contraceptive Agents, Progestin--side effects
|
| 650 |
|
4 |
|a Contraceptive Agents--side effects
|
| 650 |
|
4 |
|a Contraceptive Effectiveness
|
| 650 |
|
4 |
|a Contraceptive Mode Of Action
|
| 650 |
|
4 |
|a Depo-provera--side effects
|
| 650 |
|
4 |
|a Developed Countries
|
| 650 |
|
4 |
|a Family Planning
|
| 650 |
|
4 |
|a Medroxyprogesterone Acetate--side effects
|
| 650 |
|
4 |
|a North America
|
| 650 |
|
4 |
|a Northern America
|
| 650 |
|
4 |
|a Reversibility
|
| 650 |
|
4 |
|a United States
|
| 650 |
|
7 |
|a Contraceptive Agents
|2 NLM
|
| 650 |
|
7 |
|a Contraceptive Agents, Female
|2 NLM
|
| 650 |
|
7 |
|a Medroxyprogesterone Acetate
|2 NLM
|
| 650 |
|
7 |
|a C2QI4IOI2G
|2 NLM
|
| 773 |
0 |
8 |
|i Enthalten in
|t Contraception Report
|d 1993
|g 5(1994), 1 vom: 18. März, Seite 1-2
|w (DE-627)NLM09824602X
|7 nnns
|
| 773 |
1 |
8 |
|g volume:5
|g year:1994
|g number:1
|g day:18
|g month:03
|g pages:1-2
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 5
|j 1994
|e 1
|b 18
|c 03
|h 1-2
|